Sova Pharmaceuticals, is a biopharmaceutical company engaged in the discovery and development of small therapeutics for the treatment of inflammatory and neuropathic pain.
Sova Pharmaceuticals, Inc.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sova-pharmaceuticals-inc.” connections=”true” suffix=””]
The Companys Technology is based on modulation of cystathionine-?-lyase (CSE), a novel enzymatic target involved in the production of hydrogen sulfide(H2S), which imparts a multi-modal effect across various ion channels involved in nociception and signal transmission.
Avlon Ventures provided an Undisclosed funding to Sova pharmaceuticals for the development of therapeutics to treat central sleep apnea. Also, ResMed Inc., provided a undisclosed funding to Sova Pharmaceuticals.